An improved controlled release dosage form for once-daily administration of carvedilol is
described. The controlled release dosage form comprises a therapeutically effective amount …

0001. This application is a continuation-in-part of US patent application Ser. No. 09/748,566
filed Dec. 22, 2000, the contents of which are hereby incorporated by reference, which was a …

WO2003035039A1 - Methods of treatment using a gastric retained losartan dosage - Google
Patents WO2003035039A1 - Methods of treatment using a gastric retained losartan dosage …

US6664284B2 - Stabilized carvedilol injection solution - Google Patents US6664284B2 -
Stabilized carvedilol injection solution - Google Patents Stabilized carvedilol injection solution …

A medical composition for external use comprising a proline ester represented by formula
(I):## STR1## wherein R 1 and R 2 are as defined in the specification, or a prolinol ester …

1987-12-21 Assigned to RORER PHARMACEUTICAL CORPORATION, A DE CORP.
reassignment RORER PHARMACEUTICAL CORPORATION, A DE CORP. ASSIGNMENT …

US4902514A - Dosage form for administering nilvadipine for treating cardiovascular
symptoms - Google Patents US4902514A - Dosage form for administering nilvadipine for …

An oral composition contains 3-5-4-(cyclopentyloxy)-2-hydroxybenzoyl-2-(3-hydroxy-1, 2-
benzisoxazol-6-yl) methoxyphenylpropionic acid or a salt thereof and polyvi nylpyrrolidone …

Attorney, Agent, or Firm-Darby & Darby 3,074,847 1/1963 Bigsby. 3,752,814 8/1973
Fluckiger et al.. 57 ABSTRACT 3,752,888 8/1973 Fluckiger et al.. 3,849,562 11/1974 …

4.913, 906. A 4/1990 Friedman et al. 4,988,731. A 1/1991 Meade 5,009,897 A 4/1991
Brinker et al. 5,017,613 A 5/1991. Aubert et al. 5,019,398 A 5/1991 Daste 5,055,306 A …